Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.5900
-0.0500 (-7.81%)
Jul 31, 2026, 3:53 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 345.35 million as of July 31, 2026. Its market cap has decreased by -85.25% in one year.
Market Cap
345.35M
Enterprise Value
-772.47M
Revenue
669.23M
Ranking
n/a
PE Ratio
106.29
Stock Price
0.59
ChartMarket Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 345.35M, a decrease of -93.37%. That is a compound annual growth rate of -47.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 345.35M | -40.40% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 67.12B |
| Adicon Holdings | 2.35B |
| Guanze Medical Information Industry (Holding) | 2.27B |
| Mega Genomics | 1.59B |
| Kindstar Globalgene Technology | 937.29M |
| China Biotech Services Holdings | 604.95M |
| Biosino Bio-Technology and Science Incorporation | 454.38M |
| Zhong Ji Longevity Science Group | 241.93M |